These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2719469)

  • 1. Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia.
    Mertens JC; Dekker W; Ligtvoet EE; Blok P
    Antimicrob Agents Chemother; 1989 Feb; 33(2):256-7. PubMed ID: 2719469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Campylobacter pylori: its role in gastritis and peptic ulcer disease.
    Hornick RB
    Curr Clin Top Infect Dis; 1989; 10():157-73. PubMed ID: 2679692
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical, endoscopic and histologic findings in 1,100 patients of whom 574 were colonized by Campylobacter pylori].
    Deltenre M; Nyst JF; Jonas C; Glupczynski Y; Deprez C; Burette A
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):89B-95B. PubMed ID: 2744327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of Helicobacter pilori: reasons to believe it].
    Amouretti M
    Rev Prat; 1990 Feb; 40(4):339-40. PubMed ID: 2305196
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of Campylobacter pylori in gastritis, non-ulcer dyspepsia and ulcer. A critical observation].
    Fritsch WP
    Med Klin (Munich); 1989 Aug; 84(8):400-4. PubMed ID: 2677634
    [No Abstract]   [Full Text] [Related]  

  • 6. The relation between Campylobacter pylori and inflammatory cell infiltration of antral mucosa in patients with dyspepsia.
    Chang FY; Lai KH; Lu LC; Chang YR; Wu TC; Tsay SH
    Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):8-12. PubMed ID: 2754423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication.
    Trespi E; Broglia F; Villani L; Luinetti O; Fiocca R; Solcia E
    Scand J Gastroenterol; 1994 Oct; 29(10):884-8. PubMed ID: 7839094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-ulcer dyspepsia and Campylobacter pylori gastritis: to treat or not to treat?
    Talley NJ
    Med J Aust; 1987 Nov; 147(9):471-2. PubMed ID: 3670207
    [No Abstract]   [Full Text] [Related]  

  • 9. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and Campylobacter-associated gastritis.
    Veldhuyzen van Zanten SJ; Tytgat KM; Jalali S; Goodacre RL; Hunt RH
    J Clin Gastroenterol; 1989 Oct; 11(5):496-501. PubMed ID: 2677123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular gastritis and Helicobacter pylori.
    Bujanover Y; Konikoff F; Baratz M
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):41-4. PubMed ID: 2388131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topographic association between active gastritis and Campylobacter pylori colonisation.
    Bayerdörffer E; Oertel H; Lehn N; Kasper G; Mannes GA; Sauerbruch T; Stolte M
    J Clin Pathol; 1989 Aug; 42(8):834-9. PubMed ID: 2768523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug-induced dyspepsia--is Campylobacter pyloridis implicated?
    Doube A; Morris A
    Br J Rheumatol; 1988 Apr; 27(2):110-2. PubMed ID: 3365528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Helicobacter pylori infection, gastritis and non-ulcer dyspepsia--is there a connection?].
    Malfertheiner P; Cooreman M
    Z Gastroenterol Verh; 1991 Mar; 26():289-90. PubMed ID: 1714178
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
    Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
    Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacter pylori and non-ulcer dyspepsia.
    Rokkas T; Pursey C; Uzoechina E; Dorrington L; Simmons NA; Filipe MI; Sladen GE
    Am J Gastroenterol; 1987 Nov; 82(11):1149-52. PubMed ID: 3673994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit.
    Malfertheiner P
    Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S9-11. PubMed ID: 11686231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit.
    Koletzko L; Macke L; Schulz C; Malfertheiner P
    Best Pract Res Clin Gastroenterol; 2019; 40-41():101637. PubMed ID: 31594649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori gastritis and non-ulcer dyspepsia in childhood. Efficacy of one-week triple antimicrobial therapy in eradicating the organism.
    Cucchiara S; Salvia G; Az-Zeqeh N; D'Armiento FD; De Petra MR; Rapagiolo S; Campanozzi A; Emiliano M
    Ital J Gastroenterol; 1996; 28(8):430-5. PubMed ID: 9032584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could gastric histology be a useful marker for making decision on Helicobacter pylori eradication therapy in patients with dyspepsia?
    Arruda SM; Forones NM; Jucá NT; de Barros KS
    Arq Gastroenterol; 2009; 46(3):209-13. PubMed ID: 19918688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.